Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
367
datasets available to search
ShareScore release 0.9.0
Dataset results
367 results for “Ibrutinib”
Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03447808. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study About Combination CHOP-21, Obinutuzumab and Ibrutinib in Untreated Young High Risk DLBCL Patients.
ClinicalTrials.gov study NCT02670317. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
ClinicalTrials.gov study NCT02203526. IPD Sharing: YES. Countries: 1. Publications: 0.
Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL
ClinicalTrials.gov study NCT04908228. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations
ClinicalTrials.gov study NCT03513562. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04061850. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Long-term Extension Study of PCI-32765 (Ibrutinib)
ClinicalTrials.gov study NCT01804686. IPD Sharing: Not stated. Countries: 30. Publications: 0.
Study to Assess the Bioequivalence of Ibrutinib 140 Milligram (mg) Tablet to 140 mg IMBRUVICA Capsule
ClinicalTrials.gov study NCT02877225. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01886859. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma
ClinicalTrials.gov study NCT02451111. IPD Sharing: NO. Countries: 6. Publications: 0.
A Study of BNC105P Combined With Ibrutinib
ClinicalTrials.gov study NCT03454165. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
ClinicalTrials.gov study NCT04840602. IPD Sharing: YES. Countries: 1. Publications: 0.
A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL)
ClinicalTrials.gov study NCT04129710. IPD Sharing: YES. Countries: 1. Publications: 0.
Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma
ClinicalTrials.gov study NCT04450173. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04016636. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cardiovascular Complications of Ibrutinib Therapy
ClinicalTrials.gov study NCT05939752. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02827617. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04771507. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Ibrutinib in Relapsed Nodular Lymphocyte-predominant Hodgkin Lymphoma (NLPHL)
ClinicalTrials.gov study NCT02626884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Ibrutinib in Healthy Participants
ClinicalTrials.gov study NCT01626651. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.